Compare PCVX & PNFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCVX | PNFP |
|---|---|---|
| Founded | 2013 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 7.1B |
| IPO Year | 2020 | N/A |
| Metric | PCVX | PNFP |
|---|---|---|
| Price | $46.76 | $95.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 14 |
| Target Price | $101.67 | ★ $112.23 |
| AVG Volume (30 Days) | ★ 1.5M | 886.7K |
| Earning Date | 11-04-2025 | 01-20-2026 |
| Dividend Yield | N/A | ★ 1.00% |
| EPS Growth | N/A | ★ 49.26 |
| EPS | N/A | ★ 7.83 |
| Revenue | N/A | ★ $1,885,186,000.00 |
| Revenue This Year | N/A | $31.05 |
| Revenue Next Year | N/A | $121.72 |
| P/E Ratio | ★ N/A | $12.26 |
| Revenue Growth | N/A | ★ 21.58 |
| 52 Week Low | $27.66 | $81.57 |
| 52 Week High | $94.60 | $127.85 |
| Indicator | PCVX | PNFP |
|---|---|---|
| Relative Strength Index (RSI) | 51.97 | 67.49 |
| Support Level | $43.78 | $92.53 |
| Resistance Level | $48.11 | $94.49 |
| Average True Range (ATR) | 1.99 | 2.44 |
| MACD | -0.49 | 0.84 |
| Stochastic Oscillator | 42.99 | 98.11 |
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. It operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.